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In order to gain a more comprehensive understanding of the aetiology of apolipoprotein E4 genotype-cardiovascular disease (CVD)
associations, the impact of the apoE genotype on the macrophage inﬂammatory response was examined. The murine monocyte–macro-
phage cell line (RAW 264.7) stably transfected to produce equal amounts of human apoE3 or apoE4 was used. Following LPS stimu-
lation, apoE4-macrophages showed higher and lower concentrations of tumour necrosis factor alpha (pro-inﬂammatory) and interleukin
10 (anti-inﬂammatory), respectively, both at mRNA and protein levels. In addition, increased expression of heme oxygenase-1 (a stress-
induced anti-inﬂammatory protein) was observed in the apoE4-cells. Furthermore, in apoE4-macrophages, an enhanced transactivation
of the key redox sensitive transcription factor NF-jB was shown. Current data indicate that apoE4 macrophages have an altered inﬂam-
matory response, which may contribute to the higher CVD risk observed in apoE4 carriers.
 2007 Elsevier Inc.
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Open access under CC BY license.Apolipoprotein E (apoE) is a polymorphic multifunc-
tional protein with three common isoforms in humans
(E2, E3, and E4). ApoE3 is the wild-type and most com-
mon isoform, while apoE4 carriers account for about
25% of the Caucasian population [1]. Presence of the
apoE4 allele is associated with a 40–50% higher risk of car-
diovascular disease (CVD) [2] and apoE4 is the major
known genetic risk factor for maturity-onset Alzheimer’s
disease (AD) [3].
Although apoE4 is strongly linked to both diseases, the
molecular basis of these associations remains uncertain.
Traditionally, the diﬀerential risk has been attributed to the0006-291X 2007 Elsevier Inc.
doi:10.1016/j.bbrc.2007.03.150
* Corresponding author. Fax: +49 4318802628.
E-mail address: rimbach@foodsci.uni-kiel.de (G. Rimbach).
Open access under CC BY license.increased low density lipoprotein cholesterol (8%) observed
in apoE4 carriers, but it is becoming increasingly evident
that this alone cannot explain the disease diﬀerential [4].
ApoE is not only synthesised by the liver, but also in the
brain and by resident macrophages [5] in the atheroscle-
rotic wall, where it exerts atheroprotective actions,
independent of its role in lipid metabolism [6]. These local-
ised functions include regulation of smooth muscle cell
migration and proliferation [7], inhibition of adhesion
molecule expression in endothelial cells [8] and inhibition
of platelet aggregation [9]. In addition to its paracrine
eﬀect on surrounding cells, apoE has also been shown to
impact on macrophage function by promoting cholesterol
eﬄux [10] and modulating NO production [11]. Inﬂamma-
tion and oxidative stress are key features of the pathology
Table 1
PCR primers and conditions
Sequence (50–30) Annealing T
b-Actin F: GACAGGATGCAGAAGGAGATTACT 55
R: TGATCCACATCTGCTGGAAGGT
TNFa F: CATCTTCTCAAAATTCGAGTGACAA 55
R: TGGGAGTAGACAAGGTACAACCC
IL1b F: CAACCAACAAGTGATATTCTCCATG 55
R: GATCCACACTCTCCAGCTGCA
IL6 F: CTGCAAGAGACTTCCATCCAGTT 60
R: GAAGTAGGGAAGGCCGTGG
MIP1-a F: CCTCTGTCACCTGCTCAACA 55
R: GATGAATTGGCGTGGAATCT
IL10 F: GGTTGCCAAGCCTTATCGGA 60
R: ACCTGCTCCACTGCCTTGCT
EF2 F: GCGGTCAGCACAATGGCATA 58
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which have largely focussed on brain biology and neurode-
generation [12,13] have reported on the immuno-modula-
tory properties of apoE and its impact on inﬂammatory
mediators [14]. However, little is known about the possible
role of apoE genotype as a mediator of the macrophage
innate immune and inﬂammatory responses in relation to
CVD.
Using a murine macrophage cell line, which has been
stably transfected with human apoE3 or apoE4, we have
recently showed that apoE isoform aﬀects macrophage oxi-
dative status [15], and now we hypothesise that this may be
accompanied by an altered inﬂammatory response. Fur-
thermore, the impact of genotype on the activity of the
transcription factor nuclear factor jB (NF-jB), which is
known to play a major role in modulating the inﬂamma-
tory response, will be presented.R: GACATCACCAAGGGTGTGCAG
HO-1 F: GTGGAGACGCTTTACGTAGTGC 58
R: GACATCACCAAGGGTGTGCAG
Note. F, forward primer; R, reverse primer; IL, interleukin; TNFa,
tumour necrosis factor a; MIP1a, macrophage inﬂammatory protein 1 a;
EF2, elongation factor 2; HO-1, heme oxygenase-1.Methods
Cell culture. RAW 264.7 murine macrophage cell lines, stably trans-
fected with either human apoE3 or apoE4 were kindly given by
Dr. B. Pitas (Gladstone Institute, UCSF, USA). Cells were genotyped for
human apoE3 and apoE4 by the method of Hixson and Vernier [16] and
apoE concentrations were measured in supernatants to ensure that
secreted levels in 24 h were physiological and comparable among the two
clones. Mean (SEM) levels of 1.38 (0.38) and 1.36 (0.38) lg/mg cell protein
were secreted in 24 h by apoE3 and apoE4 cells, respectively, as has been
previously reported [15]. Cells were cultured in Dulbecco’s modiﬁed
Eagle’s medium supplemented with 10% foetal bovine serum, 4 mM
L-glutamine, 100 U/ml penicillin and 100 lg/ml streptomycin and
100 lg/ml G-418. Macrophages were grown in a humidiﬁed incubator at
37 C and 5% CO2. Cells were incubated with lipopolysacharide (LPS)
(Salmonella enteriditis, Sigma–Aldrich, Taufkirchen, Germany) for
zdiﬀerent time-periods depending on the outcome of interest.
Cytokine levels. Cells were stimulated with increasing concentrations of
LPS (0–10 lg/ml) for 4 h. Supernatants were collected for analysis 20 h later.
Cytokine concentrations were measured using commercial ELISA kits
according to the manufacturer’s instructions. Tumour necrosis factor alpha
(TNFa) was determined by the Quantikinemouse TNFa kit (R&DSystems,
Wiesbaden, Germany), Interleukin (IL) 6 and 10 were measured using the
Mouse Biotrak ELISA systems (AmershamBiosciences, Freiburg, Germany),
and IL1b and macrophage inﬂammatory protein-1alpha (MIP1a) were
determinedwith themouseRayBioELISAkits fromRayBiotech (Norcross,
USA). Values were normalised for total cell protein which was determined
using the BCA assay (Pierce Biotechnology, Rockford, USA).
Cytokine and heme oxygenase-1 (HO-1) mRNA levels. Cells were
stimulated with LPS (1 lg/ml) for 1 h to determine TNFa mRNA levels
and for 6 h to determine mRNA levels for IL1b, IL6, IL10, and MIP1a.
The time-points were chosen on the basis of maximum mRNA expression
for each cytokine in a time-course experiment (data not shown). Total
RNA was isolated with the RNeasy Mini Kit (Qiagen, Hilden, Germany).
One step RT-PCR was carried out using the QuantiTectSYBRGreen
RT-PCR kit (Qiagen) according to supplier instructions. For HO-1, cells
were stimulated with LPS (1 lg/ml) for 24 h and RNA was isolated by
acid guanidinium thiocyanate–phenol–chloroform extraction and reverse
transcription was carried out with oligo-dT primers for 1 h at 42 C using
MMLV reverse transcriptase, according to the manufacturer’s instructions
(Promega, Madison, WI, USA). Real-time RT-PCR was performed with
the SYBR Green qPCR Kit (Finnzymes, Espoo, Finland). For all
reactions, the Rotor Gene RG-3000 (Corbett Research) cycler was used
and relative quantiﬁcation of gene expression was calculated based on the
2DDCt method (b-actin or elongation factor 2 were used as housekeeping
genes). Primers and cycling conditions are shown in Table 1.Transcription factor activity. The NF-jB-secretory alkaline phospha-
tase (NF-jB-SEAP) (Clontech, BD Biosciences, Palo Alto, USA) reporter
construct was used to measure the binding of transcription factors to the j
enhancer, and the activation of this pathway. Cells growing in 24 well
plates were transiently transfected with 0.5 lg of the vector by SuperFect
transfection Reagent (Qiagen) according to the manufacturer’s protocol.
Twenty-four hours later, cells were stimulated with varying concentrations
of LPS (0–1 lg/ml). At 6, 12, and 24 h, the cell culture media was removed
and stored for analysis. The chemiluminescent SEAP assay (Clontech) was
carried out as has been previously described [17]. Values were normalised
for total cell protein determined by the BCA assay (Sigma).
Western blot analysis for heme oxygenase-1 (HO-1). Total cellular
protein was isolated using ice-cold lysis buﬀer (1· PBS, 10 mM phenyl-
methylsulfonyl ﬂuoride (PMSF), 10 mM leupeptine, 10 mM aprotinin and
1%TritonX-100). Samples were centrifuged (10 min, 8000g, 4 C) and clear
supernatants were collected. Twenty-ﬁve micrograms of protein was loaded
on 12% SDS–PAGE gel followed by transfer to nitrocellulose membrane
PROTRAN (Perkin-Elmer Life Sciences, Boston, USA). Following over-
night blocking (4 C in 5% non-fat milk), membranes were probed with
polyclonal antibodies against HO-1 (Stressgen Biotech, Canada) and
monoclonal antibodies against a-tubulin (both diluted 1:1000 in TTBSwith
3% albumin) at room temperature for 1.5 h followed by anti-rabbit HRP-
linked secondary antibodies (Cell Signalling Technology,USA) (1:10,000 in
TTBS with 3% albumin) for 40 min at room temperature. Blots were
developed with SuperSignal West Pico Chemiluminescent Substrate (Pierce
Biotechnology) according to the manufacturer’s instructions.
Statistical analysis. Statistical calculations were conducted with SPSS
Version 13.0. T-Tests (for independent samples) were performed to com-
pare the outcomes between apoE3 and apoE4 cells. In the absence of
normal distributed data, Mann–Whitney U-test was used. Results are
expressed as means ± SEM and signiﬁcance was accepted at P < 0.05.Results
Cytokine protein and mRNA levels
Stimulation of cells with increasing concentrations of
LPS (0–10 lg/ml) resulted in a dose–response accumula-
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Fig. 1. Cytokine production in RAW 264.7-apoE3 and -apoE4 following
stimulation with increasing concentrations of LPS (0–10 lg/ml) for 4 h.
Supernatants were collected for ELISA analysis 20 h later. (A) IL1b, (B)
MIP1a, (C) IL6, (D) TNFa, (E) IL10. Data are expressed as means ±
SEM of three independent experiments performed in duplicate.
*P < 0.05, **P < 0.01, comparing E3- vs. E4-cells at each LPS
concentration.
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apoE3 and -apoE4 cells (Fig. 1). In the non stimulated
cells, levels of cytokines were under the limit of detection.
In the cases of IL1b and MIP1a (Fig. 1A and B), there
was a tendency for apoE4 expressing cells to secrete
higher levels of cytokines at the majority of LPS concen-
trations tested, although the inter-group diﬀerences did
not reach statistical signiﬁcance (Fig. 1A and B). In addi-
tion, no genotype mediated diﬀerences in the IL6 concen-
trations detected in the media were observed (Fig. 1C). In
contrast apoE4-macrophages produced 99%, 62%, 54%,
and 83% more TNFa than E3 cells when stimulated at
0.1, 0.4, 0.8, and 10 lg/ml LPS (Fig. 1D). Furthermore,
when IL10, an anti-inﬂammatory cytokine, was measured
in the culture media, it was observed that apoE4-cells
secreted lower concentrations of the cytokine, at all three
LPS concentrations tested, with the diﬀerences reaching
signiﬁcance at the higher LPS concentrations (0.8 and
10 lg/ml) (Fig. 1E).
To examine whether the diﬀerences in cytokine accu-
mulation in the cell culture media were associated with
diﬀerences in cytokine gene expression, the mRNA levels
were measured by quantitative reverse transcription PCR
analysis. Gene expression proﬁles revealed to be compa-
rable to the apoE genotype mediated diﬀerences in the
cytokine levels in the media, with 68%, 60% and 32%
higher levels of mRNA for IL1b, MIP1a, and TNFa,
respectively observed in the apoE4 transfected cells
(Fig. 2). No diﬀerences could be observed in the mRNA
levels of IL6 between genotypes and similar to the
cytokine accumulation, IL10 mRNA levels, although
not statistically diﬀerent were 15% lower in the apoE4
cells.
NF-jB promoter activity
Our results demonstrate stronger NF-jB pathway acti-
vation in the apoE4- versus the apoE3-macrophages
(Fig. 3A). In non-stimulated cells, NF-jB activity was
80% higher in apoE4 cells. Following stimulation for 6 hm
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Fig. 2. Cytokine mRNA levels measured using reverse transcription real-
time PCR in RAW 264.7-apoE3 and -apoE4 following stimulation with
LPS (1 lg/ml) for 6 h or 1 h (TNFa). Results are calculated with the
2DDCt method and data are expressed as means ± SEM of three
independent experiments performed in duplicate. *P < 0.05, **P < 0.01,
***P < 0.001, comparing E3- vs. E4-cells at each LPS concentration.
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Fig. 3. (A) NF-jB activity detected with alkaline phosphatase reporter
gene assay in RAW 264.7-apoE3 and -apoE4 following stimulation with
increasing concentrations of LPS (0–1 lg/ml) for 6 h. (B) NF-jB activity
following stimulation with LPS (0.1 lg/ml) for 6, 12, and 24 h. Results are
calculated as chemiluminescence units corrected for total protein, and as
fold change of apoE3 controls. Data are expressed as means ± SEM of
three independent experiments performed in duplicate. *P < 0.05,
**P < 0. 01, ***P < 0.001 comparing E3- vs. E4-cells at each LPS
concentration; (C) control non-stimulated cells.
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Fig. 4. (A) HO-1 mRNA levels detected with reverse transcription real-
time PCR following stimulation with LPS (1 lg/ml) for 24 h. Results are
calculated with the 2DDCt method and data is expressed as mean ± SEM
of four independent experiments performed in duplicate. *P < 0.05,
***P < 0.001, comparing E3- vs. E4-cells at each LPS concentration. (B)
HO-1 levels as determined by Western blotting in relation to a-tubulin in
RAW 264.7-apoE3 and -apoE4 under baseline conditions (control) and
following stimulation with LPS (1 lg/ml) for 24 h.
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in both cell lines. In apoE3 expressing macrophages, NF-
jB activity increased 2.5-fold (P < 0.005) at a concentra-
tion of 0.01 lg/ml, with no further increase evident with
increasing concentrations of LPS. In E4 cells, a higher acti-
vation of NF-jB (4.2-fold change, P < 0.005) was evident
in cells stimulated with 0.01 lg/ml LPS, with a maximum
5-fold increase relative to apoE3 controls evident follow-
ing stimulation with 0.1 lg/ml LPS (Fig. 3A). Comparable
diﬀerences between genotypes on NF-jB activity were
observed at 12 and 24 h, with a time-dependent accumula-
tion of alkaline phosphatase in the cell culture media evi-
dent after LPS (0.1 lg/ml) stimulation, with 100%, 64%,
and 48% diﬀerences between genotypes evident at 6, 12,
and 24 h, respectively (Fig. 3B).Heme oxygenase-1 (HO-1) protein and mRNA expression
Western blotting analysis showed higher HO-1 protein
concentrations in apoE4 macrophages in both untreated
(controls) and LPS (1 lg/ml) treated cells (Fig. 4B). The
gene expression proﬁles were consistent with protein levels,
with control and LPS stimulated cells expressing apoE4,producing 235% and 180% higher HO-1 mRNA relative
to apoE3-macrophages (Fig. 4A).
Discussion
We have previously reported a higher circulating [18]
and macrophage [15] oxidative stress status associated with
the E4 allele. Here, we extend these ﬁndings by reporting
on an impact of apoE genotype on the inﬂammatory com-
ponent of the innate immune response.
A murine monocyte-macrophage cell line (RAW 264.7)
stably transfected to express either human apoE3 or apoE4
at similar concentrations and within the physiological range
was used, so that the isoform-eﬀects observed were apoE
concentration-independent. In addition, LPS, a Toll-like
receptor 4 (TLR 4) ligand that triggers cytokine expression
by activation of a signalling cascade, was applied to investi-
gate innate immune response, given that it is a commonly
used approach, and that TLR4 activation is regarded to
be relevant in the pathogenesis of atherosclerosis [19].
Following LPS stimulation, higher mRNA levels of the
pro-inﬂammatory cytokines TNFa and, IL1b, and the che-
mokine, MIP1a, with a trend towards lower levels of the
anti-inﬂammatory cytokine IL10 were evident in the apoE4
cell line. No diﬀerences were observed for IL6, which is
known to act as both a pro- and anti-inﬂammatory media-
tor. Furthermore, these changes were reﬂected by the pro-
tein levels in the medium with the greatest diﬀerences
evident for TNFa and IL10.
TNFa is pleiotropic and one of the most important pro-
inﬂammatory and immuno-modulatory cytokines involved
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ipates in the recruitment and activation of inﬂammatory
cells into the vessel wall by promoting matrix degradation
[20] and by enhancing expression of adhesion molecules on
endothelial cells [21]. In contrast, IL10 is a potent anti-
inﬂammatory cytokine, which aﬀects several signalling
pathways and destabilizes the mRNA of pro-inﬂammatory
genes, to contribute in the resolution of the inﬂammatory
process [22]. Whether the higher levels of TNFa and
IL1b observed in apoE4 macrophages were partly due to
decreased levels of IL10 or due to other mechanisms
cannot be concluded. The increased pro-inﬂammatory
cytokine response observed in our apoE4 monocyte-mac-
rophage cell model is in agreement with the limited amount
of data available from other authors, which have examined
associations between apoE genotype and inﬂammation in
the brain. By using transgenic mice expressing human
apoE3 or apoE4, Lynch et al. [14] determined that apoE4
mice showed elevated systemic and brain pro-inﬂammatory
cytokines following intravenous administration of LPS,
and Ophir et al. [12] demonstrated that the expression of
inﬂammation genes was higher and more prolongated in
the brains of apoE4 following intracerebroventricular
injection of LPS. Furthermore, Maezawa et al. demon-
strated that the isoform-speciﬁc patterns in cytokine
production (apoE4 > apoE3 > apoE2) was speciﬁc of
microglia and could not be observed in astroglia cultures
[13,23]. This is particularly relevant to our studies given
that microglia share many functional characteristics with
macrophages. In addition to the increased pro-inﬂamma-
tory response, our ﬁndings reveal that apoE4 macrophages
produce decreased amounts of IL10. A recent study by
Tziakas et al. [24] shows, in accordance with our results,
that apoE4 carriers with acute coronary syndrome and
chronic stable angina patients have lower circulating levels
of IL10 than the non-apoE4 patients. Therefore taken
together with the previous ﬁndings, our data support the
hypothesis, that apoE4 carriers may show an ‘‘inﬂamma-
tory imbalance’’ between pro- and anti-inﬂammatory medi-
ators [24].
The regulation of cytokine production is highly com-
plex, but the NF-jB signalling pathway is considered a
key element, and is the most prominent and best character-
ised signal transduction pathway in TLR-mediated inﬂam-
mation. In addition, the promoter regions of the cytokines
presented in the current paper have putative jB binding
sites (see http://people.bu.edu/Gilmore/nf-kb/). NF-jB is
a redox sensitive transcription factor, and therefore it was
hypothesised that the increased oxidative stress observed
in the apoE4 macrophages could contribute to a higher
cytokine production by enhancing the activation of NF-
jB. Here, we demonstrate through a reporter gene assay,
that the activity of NF-jB under basal conditions is higher
in apoE4 than -E3 macrophages, and that upon stimula-
tion with LPS, NF-jB activity increases in both cell lines,
but the response is more augmented in the apoE4 macro-
phages. Again, this is in accordance with the results ofOphir et al. [12], who by means of microarray analysis,
determined that the genes that were more diﬀerentially
expressed between genotypes in the brain, where NF-jB-
regulated and showed that NF-jB activation was more
pronounced in the microglia of apoE4 versus apoE3 mice.
Under stress situations, the integrity of the vascular wall
is maintained by several protective mechanisms, which in
addition to anti-inﬂammatory cytokines include other pro-
teins such as inducible heme oxygenase-1 (HO-1). HO-1
catalyses the rate limiting reaction in the degradation of
heme, to yield biliverdin (with radical scavenging proper-
ties), carbon monoxide (a vascular modulator), and iron
[25]. HO-1 is expressed in response to oxidative stress,
and has been shown to be upregulated in atherosclerotic
plaques [26] and in AD lesions [27], and attenuate inﬂam-
mation and the growth of atherosclerotic plaques in trans-
genic mice models [28,29]. However, so far the production
and role of HO-1 has not been investigated in relation to
the human apoE polymorphism. Here, for the ﬁrst time,
we show that HO-1 levels are signiﬁcantly increased in
apoE4-macrophages. ApoE4-macrophages demonstrated
increased levels of HO-1 under baseline conditions, and a
stronger up-regulation of HO-1 at the mRNA and protein
levels following LPS application.
Whether HO-1 exerts anti-inﬂammatory eﬀects in apoE4
macrophages cannot be concluded from the current study.
Although the inﬂammatory response was apparently
aggravated in apoE4 cells, we cannot discard the possibility
that this could be even more exacerbated without the up-
regulation of HO-1 observed. Hence, one may consider,
that induction of HO-1 by apoE4 represents a stress-
induced protective response.
The current study is suggestive that an impact of apoE
genotype on the monocyte inﬂammatory response may
contribute to the higher CVD and AD risk observed in
humans with an apoE4 genotype. However, further clariﬁ-
cation of the molecular mechanisms, the complexity of
apoE4–HO-1 interactions, as well as the impact of apoE
genotype on inﬂammation using in vivo animal models
and human trials is needed.Acknowledgments
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